blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1737838

EP1737838 - SUBSTITUTED 4-ALKYL- AND 4-ALKANOYL-PIPERIDINE DERIVATIVES AND THEIR USE AS NEUROKININ ANTAGONISTS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  27.03.2009
Database last updated on 07.10.2024
Most recent event   Tooltip30.09.2011Lapse of the patent in a contracting state
New state(s): CY, TR
published on 02.11.2011  [2011/44]
Applicant(s)For all designated states
Janssen Pharmaceutica NV
Turnhoutseweg 30
2340 Beerse / BE
[2008/21]
Former [2007/01]For all designated states
JANSSEN PHARMACEUTICA N.V.
Turnhoutseweg 30
2340 Beerse / BE
Inventor(s)01 / JANSSENS, Frans Eduard, Janssen Pharmaceutica N.V.
Turnhoutseweg 30
B-2340 Beerse / BE
02 / SOMMEN, François Maria, Janssen Pharmaceutica N.V.
Turnhoutseweg 30
B-2340 Beerse / BE
03 / DE BOECK, B.C.A.G., Janssen Pharmaceutica N.V.
Turnhoutseweg 30
B-2340Beerse / BE
04 / LEENAERTS, Joseph E., Janssen Pharmaceutica N.V.
Turnhoutseweg 30
B-2340 Beerse / BE
 [2007/01]
Representative(s)Daelemans, Frank F.R., et al
Janssen Pharmaceutica N.V. J&J Patent Law Department Turnhoutseweg 30
2340 Beerse / BE
[2007/43]
Former [2007/01]Van Borm, Werner August H.M.
Janssen Pharmaceutica N.V. Patent Department Turnhoutseweg 30
2340 Beerse / BE
Application number, filing date05729797.004.04.2005
[2007/01]
WO2005EP51509
Priority number, dateEP2004010146708.04.2004         Original published format: EP 04101467
[2007/01]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2005097774
Date:20.10.2005
Language:EN
[2005/42]
Type: A1 Application with search report 
No.:EP1737838
Date:03.01.2007
Language:EN
The application published by WIPO in one of the EPO official languages on 20.10.2005 takes the place of the publication of the European patent application.
[2007/01]
Type: B1 Patent specification 
No.:EP1737838
Date:21.05.2008
Language:EN
[2008/21]
Search report(s)International search report - published on:EP20.10.2005
ClassificationIPC:C07D401/02
[2007/01]
CPC:
C07D409/14 (EP,KR,US); C07D401/14 (EP,KR,US); A61P1/08 (EP);
A61P11/00 (EP); A61P11/06 (EP); A61P25/00 (EP);
A61P25/04 (EP); A61P25/18 (EP); A61P25/22 (EP);
A61P43/00 (EP); A61P7/12 (EP); C07D401/02 (EP,US);
C07D401/04 (EP,US); C07D405/14 (EP,KR,US); C07D413/14 (EP,KR,US);
C07D417/14 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2007/01]
Extension statesAL08.11.2006
BA08.11.2006
HR08.11.2006
LV08.11.2006
MK08.11.2006
YU08.11.2006
TitleGerman:SUBSTITUIERTE 4-ALKYL- UND 4-ALKANOYLPIPERIDINDERIVATE UND DEREN VERWENDUNG ALS NEUROKININANTAGONISTEN[2007/01]
English:SUBSTITUTED 4-ALKYL- AND 4-ALKANOYL-PIPERIDINE DERIVATIVES AND THEIR USE AS NEUROKININ ANTAGONISTS[2007/01]
French:DERIVES 4-ALKYL-ET 4-ALKANOYL-PIPERIDINES ET UTILISATIONS DE CES DERNIERS EN TANT QU'ANTAGONISTES DE LA NEUROKININE[2007/01]
Entry into regional phase08.11.2006National basic fee paid 
08.11.2006Designation fee(s) paid 
08.11.2006Examination fee paid 
Examination procedure08.11.2006Examination requested  [2007/01]
13.03.2007Despatch of a communication from the examining division (Time limit: M04)
30.05.2007Reply to a communication from the examining division
11.06.2007Despatch of a communication from the examining division (Time limit: M02)
19.07.2007Reply to a communication from the examining division
07.09.2007Communication of intention to grant the patent
03.01.2008Fee for grant paid
03.01.2008Fee for publishing/printing paid
Opposition(s)24.02.2009No opposition filed within time limit [2009/18]
Fees paidRenewal fee
02.05.2007Renewal fee patent year 03
26.03.2008Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY21.05.2008
CZ21.05.2008
DK21.05.2008
EE21.05.2008
FI21.05.2008
LT21.05.2008
PL21.05.2008
RO21.05.2008
SI21.05.2008
SK21.05.2008
TR21.05.2008
BG21.08.2008
SE21.08.2008
GR22.08.2008
IS21.09.2008
PT21.10.2008
HU22.11.2008
[2011/43]
Former [2011/32]CZ21.05.2008
DK21.05.2008
EE21.05.2008
FI21.05.2008
LT21.05.2008
PL21.05.2008
RO21.05.2008
SI21.05.2008
SK21.05.2008
BG21.08.2008
SE21.08.2008
GR22.08.2008
IS21.09.2008
PT21.10.2008
HU22.11.2008
Former [2010/52]CZ21.05.2008
DK21.05.2008
EE21.05.2008
FI21.05.2008
LT21.05.2008
PL21.05.2008
RO21.05.2008
SI21.05.2008
SK21.05.2008
BG21.08.2008
SE21.08.2008
GR22.08.2008
IS21.09.2008
PT21.10.2008
Former [2009/27]CZ21.05.2008
DK21.05.2008
EE21.05.2008
FI21.05.2008
LT21.05.2008
PL21.05.2008
RO21.05.2008
SI21.05.2008
SK21.05.2008
BG21.08.2008
SE21.08.2008
IS21.09.2008
PT21.10.2008
Former [2009/22]CZ21.05.2008
DK21.05.2008
EE21.05.2008
FI21.05.2008
LT21.05.2008
PL21.05.2008
RO21.05.2008
SI21.05.2008
SK21.05.2008
SE21.08.2008
IS21.09.2008
PT21.10.2008
Former [2009/14]CZ21.05.2008
DK21.05.2008
FI21.05.2008
LT21.05.2008
PL21.05.2008
RO21.05.2008
SI21.05.2008
SK21.05.2008
SE21.08.2008
IS21.09.2008
PT21.10.2008
Former [2009/13]CZ21.05.2008
DK21.05.2008
FI21.05.2008
LT21.05.2008
PL21.05.2008
SI21.05.2008
SK21.05.2008
SE21.08.2008
IS21.09.2008
Former [2009/09]DK21.05.2008
FI21.05.2008
PL21.05.2008
SI21.05.2008
SE21.08.2008
IS21.09.2008
Former [2009/07]FI21.05.2008
PL21.05.2008
SI21.05.2008
SE21.08.2008
IS21.09.2008
Former [2009/05]FI21.05.2008
PL21.05.2008
SI21.05.2008
IS21.09.2008
Former [2008/50]FI21.05.2008
PL21.05.2008
SI21.05.2008
Former [2008/44]SI21.05.2008
Cited inInternational search[YD]WO9716440  (JANSSEN PHARMACEUTICA NV [BE], et al) [YD] 1,8,11,13 * claim 1; tables 6,7; compounds 1-192 *;
 [A]WO9724356  (JANSSEN PHARMACEUTICA NV [BE], et al) [A] 1,8 * the whole document *;
 [YD]WO0232867  (GLAXO GROUP LTD [GB], et al) [YD] 1,8,11,13 * claim 1 *;
 [YD]WO02062784  (HOFFMANN LA ROCHE [CH]) [YD] 1,8,11,13 * Formula IC; page 3, line 15 *;
 [PA]WO2004056805  (JANSSEN PHARMACEUTICA NV [BE], et al) [PA] 1 * the whole document ** compounds 1-10 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.